Caricamento...
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy
Alpha7 nicotinic acetylcholine receptor (α(7) nAChR) agonists may be valuable treatments for negative symptoms and cognitive impairment in schizophrenia. Unfortunately, chronic exposure to an agonist may reduce the receptor’s sensitivity. Therefore, we combined CDP-choline, a dietary source of the d...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3732552/ https://ncbi.nlm.nih.gov/pubmed/23768813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2013.05.023 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|